Sign in

CIK 0001088856 · Large accelerated filer

CORCEPT THERAPEUTICS INC

Sign in to watch
Ticker
CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770487658
Phone
650.688.8803
Business address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. 4 Planned sale See Remarks sold 1,031 shares at $114.52 ($118,068)
  3. 4 Planned sale Chief Development Officer sold 16,300 shares at an average $113.43 ($1,848,890)
  4. 4 Planned sale Chief Development Officer sold 3,700 shares at $113.12 ($418,562)
  5. 4 Planned sale See Remarks sold 20,305 shares at $114.70 ($2,329,075)
  6. 4 Open-market sale See Remarks sold 1,540 shares at $114.16 ($175,806)
  7. 144 Insider Sale of Securities
  8. 4 Planned sale Chief Financial Officer sold 80,000 shares at an average $114.71 ($9,177,109)
  9. 144 Insider Sale of Securities
  10. 144 Insider Sale of Securities
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations · Regulation FD disclosure
  13. 4 Planned sale Director sold 10,000 shares at an average $88.30 ($882,986)
  14. 4 Planned sale Chief Financial Officer sold 40,000 shares at an average $87.71 ($3,508,277)
  15. 4 Gift Chief Business Officer gave 600 shares (gift)
  16. 4 Planned sale Chief Development Officer sold 20,000 shares at an average $93.13 ($1,862,530)
  17. 144 Insider Sale of Securities
  18. 4 Planned sale See Remarks sold 25,000 shares at an average $88.35 ($2,208,737)
  19. 4 Planned sale Director sold 10,000 shares at an average $83.20 ($832,049)
  20. 4 Open-market sale Director sold 20,000 shares at $84.53 ($1,690,506)

Page 3 of 103 · 2,050 filings